APP下载

多模式联合治疗在开胸术后镇痛中的应用效果

2019-05-28刘俊孔羽曾庆武

中国当代医药 2019年12期

刘俊 孔羽 曾庆武

[摘要]目的 探討多模式联合治疗在开胸术后镇痛中的可行性。方法 选取2016年3月~2018年3月于我院就诊的60例开胸肺部手术患者作为研究对象,依据镇痛方案的不同将其分成A组(单纯自控式止痛)、B组(在A组的基础上联合肋间神经阻滞)和C组(在B组的基础上联合术中肋间神经保护),每组各20例。记录三组患者的手术时间、胸管拔除时间、住院时间及治疗前、治疗后24、48 h的平均动脉压(MAP)、心率(HR)和血氧饱和度(SpO2);根据视觉模拟(VAS)评分法评估三组患者麻醉清醒后、拔除胸管后1 d、术后1个月及术后2个月的疼痛度,并比较三组患者的不良反应发生情况。结果 C组患者的胸管拔管时间短于A组,差异有统计学意义(P<0.05);三组患者的手术时间及住院时间比较,差异无统计学意义(P>0.05)。三组患者治疗前的MAP、HR及SpO2比较,差异无统计学意义(P>0.05);B组、C组患者治疗后24 h的MAP及HR均低于A组,差异有统计学意义(P<0.05);B组、C组患者治疗后48 h的HR均低于A组,差异有统计学意义(P<0.05);C组患者治疗后48 h的HR低于B组,差异有统计学意义(P<0.05)。C组患者麻醉清醒后、拔除胸管后1 d及术后1个月的VAS评分均低于A组和B组,差异有统计学意义(P<0.05);B组患者麻醉清醒后、拔除胸管后1 d的VAS评分均低于A组,差异有统计学意义(P<0.05);三组患者术后2个月的VAS评分比较,差异无统计学意义(P>0.05)。C组患者的不良反应总发生率低于A组和B组,差异有统计学意义(P<0.05)。结论 多模式联合治疗在开胸术后镇痛中的效果显著,不良反应少。

[关键词]开胸手术;术后疼痛;肋间神经阻滞麻醉

[中图分类号] R971.2 [文献标识码] A [文章编号] 1674-4721(2019)4(c)-0098-04

Application effect of multimode combined therapy in the analgesia after thoracotomy

LIU Jun KONG Yu ZENG Qing-wu LI Zhi-yong XIONG Wei

Department of Thoracic and Cardiovascular Surgery, Xinyu People′s Hospital, Jiangxi Province, Xinyu 338000, China

[Abstract] Objective To explore the feasibility of multimode combined therapy in the analgesia after thoracotomy. Methods A total of 60 patients with thoracotomy who were admitted to our hospital from March 2016 to March 2018 were selected as research objects and they were divided into group A (simple self-controlled analgesia), group B (combined with intercostal nerve block on the basis of group A) and group C (combined with intraoperative intercostal nerve protection on the basis of group B) according to different analgesia regimens, with 20 cases in each group. The operation time, chest tube removal time, hospitalization time, and mean arterial pressure (MAP), heart rate (HR), and oxygen saturation (SpO2) before treatment, and 24, 48 h after treatment among the three groups of patients were recorded. Visual analogue scale (VAS) score was used to evaluate the pain after anesthetic awareness, 1 d after chest tube removal and at 1 month and 2 months after operation of the three groups. The incidence of adverse reactions was compared in three groups of patients. Results The chest tube removal time of group C was shorter than that of group A, and the difference was statistically significant (P<0.05). There were no significant differences in the operation time and hospitalization time among the three groups (P>0.05). There were no significant differences in the MAP, HR and SpO2 among the three groups (P>0.05). The MAP and HR of group B and group C were lower than those of group A 24 h after treatment, and the differences were statistically significant (P<0.05). The HR of group B and group C was lower than that of group A 48 h after treatment, and the differences were statistically significant (P<0.05). The HR of group C was lower than that of group B 48 h after treatment, and the difference was statistically significant (P<0.05). The VAS scores of patients in group C after anesthesia, 1 d after removal of chest tube and 1 month after operation were lower than those in group A and group B, and the differences were statistically significant (P<0.05). The VAS scores of group B after anesthesia awareness and 1 d after removal of chest tube were lower than those of group A, and the differences were statistically significant (P<0.05). There were no significant differences in VAS scores among the three groups 2 months after operation (P>0.05). The total incidence rate of adverse reactions in group C was lower than that in group A and group B, and the differences were statistically significant (P<0.05). Conclusion Multimode combined therapy has significant analgesic effect after thoracotomy with fewer adverse reactions.

[Key words] Thoracotomy; Postoperative pain; Intercostal nerve block anesthesia

开胸术后患者通常由于创伤大,损伤肋间神经等导致术后患者近期胸部剧烈疼痛以及术后慢性疼痛(CPP),严重影响预后[1]。目前临床上多采取术中肋间神经保护、术后肋间神经阻滞或应用镇痛药物等单一镇痛方案,但效果不佳[2]。闫辉等[3]研究发现,镇痛药物联合肋间神经阻滞能够有效降低患者的疼痛度,不良反应少。本研究选取我院收治的60例开胸肺部手术患者作为研究对象,旨在通过探讨多模式联合治疗在开胸术后镇痛中的可行性,以期为临床治疗提供指导,现报道如下。

登录APP查看全文